deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT04876820

Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients (EPIPHARM)

Study of the Impact of Pharmaceutical Interventions on the Medication Adherence of Epileptic Patients and Their Medication Knowledge

Sponsor: University Hospital, Lille

Conditions Epilepsy
Updated 7 times since 2021 Last updated: May 22, 2025 Started: Oct 1, 2021 Primary completion: Oct 1, 2024 Completion: Oct 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor's decesion, no inclusion since august 2022

Listed as NCT04876820, this NA trial focuses on Epilepsy and remains terminated or withdrawn. Sponsored by University Hospital, Lille, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jun 2021 – ~May 2022 · 11 months · monthly snapshotNot Yet Recruiting~May 2022 – ~Dec 2022 · 7 months · monthly snapshotRecruiting~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Jun 2025 · 6 months · monthly snapshotUnknown~Jun 2025 – present · 13 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Jun 2025 — Present [monthly]

    Terminated NA

    Status: UnknownTerminated

  2. Dec 2024 — Jun 2025 [monthly]

    Unknown NA

    Status: RecruitingUnknown

  3. Sep 2024 — Dec 2024 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Dec 2022 — Jul 2024 [monthly]

    Recruiting NA

Show 2 earlier versions
  1. May 2022 — Dec 2022 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  2. Jun 2021 — May 2022 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University Hospital, Lille
Data source: University Hospital, Lille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations